Astaxanthin treatment decreases pro-inflammatory cytokines and improves reproductive outcomes in patients with polycystic ovary syndrome undergoing assisted reproductive technology: A randomized clinical trial.

Farzane FereidouniLadan KashaniFardin AmidiMahshad KhodarahmianShahrzad ZhaeentanNegar Ajabi ArdehjaniTayebeh Rastegar

Published in: Inflammopharmacology (2024)

AST pretreatment may modify inflammation and improve ART outcomes in PCOS infertile patients. Further investigations are recommended to verify these findings.

Keyphrases

end stage renal disease
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
polycystic ovary syndrome
type diabetes
patient reported outcomes
insulin resistance
weight loss
adipose tissue
skeletal muscle
replacement therapy
anti inflammatory